Table2 Correlations between LIMT and clinical characteristics of 33 HCC cancer patients
|
Clinical parameter |
n=33 |
High |
Low |
P-value |
|
|
Sex |
Female |
9 |
6 |
3 |
0.1340 |
|
Male |
24 |
9 |
15 |
|
|
|
Age (year) |
<60 |
19 |
10 |
9 |
0.5787 |
|
≥60 |
14 |
6 |
8 |
|
|
|
Stage |
I–II |
19 |
12 |
7 |
0.0173* |
|
III–IV |
14 |
3 |
11 |
|
|
|
Tumor size (cm 3) |
<3 |
13 |
9 |
4 |
0.0270* |
|
≥3 |
20 |
6 |
14 |
|
|
|
AFP |
<20 |
16 |
8 |
8 |
0.6109 |
|
≥20 |
17 |
7 |
10 |
|
|
|
Portal vein tumor thrombus |
Yes |
7 |
4 |
3 |
0.8764 |
|
No |
26 |
14 |
12 |
|
|
|
HBsAg |
Yes |
16 |
4 |
12 |
0.0221* |
|
No |
17 |
11 |
6 |
|
AFP, alpha-fetoprotein.